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Abstract
Objective: Observation of weight loss and the maxi-
mum time that individualized dietary treatment qualita-
tive and quantitative is shown to be effective. 
Method: 4625 consultations were conducted with 616 
patients over 25 years old, in the nutrition consultation, 
using the qualitative and quantitative individualized die-
tary treatment. As a result we controlled the weight loss, 
the fat and the quality and variability of the loss, monthly 
according to sex, age and BMI in an urban area of sou-
theastern Spain. 
Results and discussion: A low level of abandonment 
was proved in men, patients older than 45 years old com-
pared to obese showed a higher degree. The quality of the 
loss was greater in men under 45 years old, overweight 
patients, however, more research is needed in this area. 
Measuring the waist and hips has led to an increasing 
interest in measuring indicators of body fat. 
Conclusion: The individualized dietary treatment has 
been proved to be effective for six months and then a 
multidisciplinary mode of this treatment is recommen-
ded. The use of new ways to assess weight loss is proposed 
taking into consideration the quality and variability of 
loss, regardless of the treatment used.
(Nutr Hosp. 2015;31:2017-2024)
DOI:10.3305/nh.2015.31.5.8648
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LA VARIABILIDAD EN LA ADHERENCIA AL 
TRATAMIENTO DIETÉTICO Y LA CALIDAD DE 
LA PÉRDIDA DE PESO: EL SOBREPESO Y LA 
OBESIDAD
Resumen
Objetivo: Observación de la pérdida de peso y el tiem-
po máximo que se muestra el tratamiento dietético indi-
vidualizado cuali-cuantitativo para ser eficaz. 
Método: 4625 consultas se llevaron a cabo con 616 pa-
cientes mayores de 25 años, en la consulta de nutrición, 
utilizando la herramienta de tratamiento dietético indivi-
dualizado cuali-cuantitativo, como resultado se controló 
la pérdida de peso, la grasa, la calidad y la variabilidad 
de la pérdida, mensualmente en función del sexo, la edad 
y el IMC en una zona urbana del sureste de España. 
Resultados y discusión: Se demostró un bajo nivel de 
abandono en los hombres, en los pacientes mayores de 
45 años, frente a los obesos que mostraron un mayor 
grado. La calidad de la pérdida fue mayor en los hom-
bres, los menores de 45 años, los pacientes con sobrepeso, 
sin embargo, se necesita más investigación en esta área. 
La medición de la cintura y las caderas ha llevado a un 
creciente interés en los indicadores de medición de grasa 
corporal. 
Conclusión: El tratamiento dietético individualizado 
ha demostrado ser eficaz en los seis meses y, posterior-
mente, se recomienda su uso en el modo multidisciplina-
rio. Se propone el uso de nuevas formas de evaluar la pér-
dida de peso: la calidad y la variabilidad de la pérdida, 
independientemente del tratamiento utilizado.
(Nutr Hosp. 2015;31:2017-2024)
DOI:10.3305/nh.2015.31.5.8648
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Introduction 
Body composition and fat mass
Weight gain corresponding to increased adipose 
deposits has a negative effect on health, including a 
greater prevalence of mortality, and a wide range of 
chronic diseases, thus contributing to poorer quality 
of life1. This research evaluated weight and fat loss 
and the quality of the weight lost. Some authors no-
ted that not all weight loss provides these health im-
provements, however the reduction of the proportion 
of body fat can be of greater significance. Therefore, 
intervention in weight loss should focus on the loss of 
body fat2,3. 
Treatment of loss, adherence and abandonment 
This clinical trial is based on the ongoing learning 
process as a stimulus for the patient, suggesting that 
said process will assist in reducing levels of abandon-
ment4. For this purpose individualised dietary treat-
ment of weight and fat loss was monitored, based on 
the time spent in the clinic, sex, age, BMI and quality 
of weight loss. This type of study may contribute to 
a possible improvement in the lines of the research 
relating to obesity, as recommended by the EASO_
SAB report. Furthermore, this line of research may 
provide a response to simple and transversal ques-
tions which could be raised in respect of any weight 
loss method5 
Theoretical Framework
Obesity at a global level continues to rise, as recent 
studies have shown, with an average increase in body 
mass index (BMI ) of 0.4 kg/m per decade from 1980 
and Spain is no exception. There has been an enor-
mous increase in new weight loss treatments, many 
of which have not been compared and contrasted and 
perhaps this is not the most appropriate course of ac-
tion3. Improvements in life style and eating habits can 
be addressed in many ways however, but the most inte-
resting objective is to achieve a healthy weight and to 
ensure that said weight change is maintained over time 
6-8
. Some authors mention the difficulty in adapting to 
the changes made, a concept known as “adherence to 
treatment”9. Abandonment is the most frequent cau-
se, at times accounting for up to 68% of grounds for 
failure of the treatment10,11. Such a high rate of aban-
donment may be motivated by: ignorance of the treat-
ment, strategies which are not adapted to the patient’s 
level of excess weight 12, women are more interested 
in altering their weight together with their life style, 
and thus their weight loss goals are not realistic11. It is 
recommended that concerted goals and strategies are 
followed in the chosen treatment13. 
Purpose of the Study
Monthly weight loss variability was observed, de-
termining the maximum recommended duration for 
use of the individualised dietary treatment and propo-
sing new forms of expression for the effectiveness of 
weight lost for any weight loss method.
Material and methods
Participants
Weight and fat loss were analysed in an individuali-
sed manner in a total of 616 patients, generating 4625 
nutrition consultations in an urban area of south eas-
tern Spain, for a period from 2006 -2012. 
The selection criteria applied were: ≥ 25 years of 
age14; with a body mass index equal to or greater than 
25 kg/m2, divided into two groups: overweight (BMI: 
25-30 kg/m2) and obesity (BMI: ≥30 kg/m2)15; without 
allergies, or known food intolerances; without inca-
pacitating psychomotor or comprehension conditions 
and carrying out the dietary recommendations given; 
and to agree to participate in this study. And as criteria 
for exclusion, all those patients who failed to comply 
with the foregoing conditions; those who have a pa-
cemaker type device fitted; who have undergone co-
rrective surgery for morbid obesity (bariatric surgery, 
fitting of gastric band or balloon or other similar de-
vices); those who request food replacement or dietary 
supplements and/or drugs; patients who required ovo-
lacto-vegetarian diets or others outside the recommen-
dations of nutritional intervention based on the food 
pyramid; and patients who need controlled diets due 
to metabolic diseases or specific intolerances, low glu-
ten, hyperphenylalaninemia , purine metabolism disor-
ders, diabetes etc.
Individualised measurement of body weight of the 
patients in the consulting room
For weighing and calculation of the body fat the 
Tanita BC-418MA body composition analysis was 
used (TANITA, Corporation of America, Arlington 
Heights, IL, USA) For the weighing process the fo-
llowing preliminary recommendations were followed: 
a homogeneous weighing timetable; no previous phy-
sical exercise that day; avoidance of excessive water 
consumption; and furthermore, in the event that the 
subject is being treated with diuretics, the dose should 
not usually vary. 
Every two weeks, in each individualised consulta-
tion the anthropometric parameters of body weight and 
body mass were measured over a maximum period of 
six months. All the anthropometric data obtained were 
noted in the patient’s file, and the data to be analysed 
were recorded on a spread sheet: treatment time, age, 
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sex, weight, height, fat content, based on which the 
initial and final BMI were calculated, the weight loss 
percentages and body fat with respect to the initial fi-
gures. 
With respect to adherence, the patient’s monthly 
attendance at the clinic was taken into account. For 
the study the patients were monitored from the start 
of treatment to the date of signing off, considering 
a maximum period of six months of treatment. An 
attempt was made to reduce the level of patient aban-
donment by facilitating communication with and 
greater access to the professional treating the pa-
tients16. In order to improve understanding and adap-
tation to the treatment, an ongoing learning process 
was developed divided into three stages: initiation 
period, perfecting phase and maintenance. During 
the final phase more extensive and less strict dietary 
guidelines were gradually introduced, particularly 
for weekends. These measures were agreed with the 
patient, and were included as part of their goals and 
nutritional planning4. 
Diet as a tool for treating weight loss 
This was based on a balanced diet which qualita-
tively and quantitatively reduces weight with recom-
mendations for increased understanding of what that 
entails, and using locally grown and sourced foods. 
The distribution of macronutrients in said diet was 
based on a hypo-lipidic diet (10-15%); with proteins 
accounting for 15-20%; and with carbohydrates adap-
ted to 60-65% avoiding those with a high glycaemic 
index. The aim was for the diet to lead to a reduction 
of 20-30% in terms of energy needs according to re-
commendations17, said energy deficit will be adapted 
on the basis of gradual weight loss obtained, thus en-
suring a continuous loss4. 
Parameters for assistance and interpretation of the 
loss
Adherence to the treatment measured as patients 
who remain: PCAC = patients who continue to attend 
the clinic. 
Patients who normalise: PN = patients who have 
been signed off as they achieved their objective. In ex-
cess weight the goal pursued was to reach a healthy 
weight or normoweight15 and in the case of the obese 
the goal is to reach overweight status. 
Patients who abandon the treatment: PDT = patients 
who fail to continue and who have not reached any of 
the goals mentioned in the PN. 
Percentage of weight lost: %WL=100 x (Weight lost 
between visits to the clinic/initial weight ). 
Percentage of fat lost: %FL=100 x (Fat lost between 
visits to the clinic/initial fat).
Quality of loss: QL= %FL/%WL.
Variability %WL: V%WL=100 x (%WLto-
tal-%WLmonth) / % WLtotal. 
Variability %FL: V%FL=100 x (%FLtotal-% FL-
month) / % FLtotal.
V%TWLS: Variability percentage of total weight 
loss of the sample (n=616).
V%FLTS: Variability in the percentage of fat loss 
total sample (n=616).
Both parameters help to assess how the weight and 
fat loss has been each month in relation to the total 
weight and fat lost. They may be used for any age 
group, sex, BMI and physical activity carried out. It 
is interpreted that at the lowest value of variability, the 
loss of that month was more significant with respect to 
the remainder of the treatment. 
Statistical Analysis
The data was processed statistically using the IBM 
SPSS Statistics 22.0 package. Non parametric studies 
were used between the different subgroups as nor-
mal distribution was not available. Significations for 
p<0.05 were considered.
Results 
Description of the participants
The initial sample consisted of 616 patients, the ma-
jority of whom were women (69%), aged between 25 
and 44 (52%) and obese (55%) (Table I). The evolu-
tion of patients over a six month treatment period is 
represented monthly in figure 1. Analysing these pa-
rameters on a month by month basis, and in relation 
to groups of sex, age and the degree to which they are 
overweight or obese, it was noted that men, the over 
45s and the obese displayed a greater level of abandon-
ment. In the case of patients who were signed off be-
cause they successfully completed the treatment (they 
normalised) there was an alternation between under 
and older than 45 years, as in the case of overweight 
and obese, however, men showed a tendency to grea-
ter success in completing the treatment than women 
(Table I). 
Effectiveness of the loss between variables and the 
treatment time 
As a result of the losses obtained through attending 
the clinic, the aforementioned parameters are highligh-
ted as indicated in table II. Men showed a significantly 
greater % of fat and weight loss than women, though 
this became equal after the fourth month. In the case 
of those under 45 years, the % of fat loss was greater 
than in those over 45 years which evened out as the 
treatment progressed. There was only a significant di-
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fference between those who were overweight and the 
obese during the first month (Table II). 
In the evolution of the treatment over time, accor-
ding to sex, age and BMI, the variation of %WL and 
%FL a considerable loss was noted up to the third 
month of treatment, and subsequently this dimini-
shed. The quality of loss (QL) reduced gradually as 
the treatment progressed in men and women over 45, 
however, in women over 45 it gradually increased. In 
the variability of monthly weight and fat loss it may 
be seen that effectiveness is not as great as in previous 
cases, as the monthly and total loss of the treatment 
is taken into account. In the V%WL in men, patients 
aged 25 to 44 and with excess weight, the monthly loss 
reduced gradually however in the case of women, the 
patients over 45 and the obese gradually reduced the 
effectiveness of the loss up to the final months despite 
the fact that there were improvements in the final mon-
Table I 
Total sample, remaining and abandoning, according to distribution of the sample by sex,  
age groups and excess weight or obesity
Treatment Men  
n=188
Women  
n=428 
25-44 years 
n=322 
>45 years  
n=294
Overweight 
n=275 
Obesity  
n=341 
1st month
PCAC (n (%)) 188(100) 424 (99,1) 319 (99,1) 293(99,7) 274 (99,6) 338(99,1)
↓ BMI < 25 (n (%)) 18 (9,6) 75 (17,5) 67 (20,8) 26 (8,8) 92 (33,5) 1(0,3)
↓ BMI < 30 >25 (n (%)) 45 (23,9) 57 (13,3) 47 (14,6) 55 (18,7) NP 99 (29)
PDT (n (%)) 0 4 (0,9) 3 (0,9) 1(0,3) 1 (0,4) 3 (0,9)
2nd month
PCAC (n (%)) 126 (67) 280 (65,4) 200 (62,1) 206 (70,1) 173 (62,9) 233 (68,3)
↓ BMI < 25 (n (%)) 14 (7,5) 61 (14,3) 51(15,8) 24 (8,16) 74 (26,9) 1 (0,3)
↓ BMI < 30 >25 (n (%)) 40 (21,3) 46 (10,7) 35 (10,9) 51 (17,3) NP 77 (22,6)
PDT (n (%)) 44 (23.4) 69 (16,1) 52 (16,1) 61 (20,7) 9 (3,3) 104 (30,5)
3rd month
PCAC (n (%)) 68 (36,2) 116 (27,1) 78 (24,2) 106 (36,1) 54 (19,6) 130 (38,1)
↓ BMI < 25 (n (%)) 3 (1,6) 23 (5,4) 16 (5) 10 (3,4) 25 (9,1) 1 (0,3)
↓ BMI < 30 >25 (n (%)) 29 (15,4) 28 (6,5) 23 (7,1) 34 (11,6) NP 45 (13,2)
PDT (n (%)) 44 (23,4) 103 (24,1) 71 (22) 76 (25,9) 45 (16,4) 102 (29,9)
4th month
PCAC (n (%)) 35 (18,6) 37 (8,6) 29 (9) 43 (14,6) 11 (4) 61 (17,9)
↓ BMI < 25 (n (%)) 3 (1,6) 0 3 (0,9) 0 2 (0,7) 1 (0,3)
↓ BMI < 30 >25 (n (%)) 16 (8,5) 14 (3,3) 11 (3,4) 19 (6,5) NP 25 (7,3)
PDT (n (%)) 30 (16) 56 (13,1) 33 (10,2) 53 (18) 18 (6,5) 68 (19,9)
5th month
PCAC (n (%)) 19 (10.1) 15 (3,5) 13 (4) 21 (7,1) 3 (1,1) 31 (9,1)
↓ BMI < 25 (n (%)) 0 0 0 0 0 0
↓ BMI < 30 >25 (n (%)) 11 (5,9) 7 (1,6) 7 (2,2) 11 (3,7) NP 8 (2,3)
PDT (n (%)) 13 (6,9) 22 (5,1) 13 (4) 22 (7,5) 6 (2,2) 29 (8,5)
6th month
PCAC (n (%)) 9 (4,8) 6 (1,4) 4 (1,2) 11 (3,7) 1 (0,4) 14 (4,1)
↓ BMI < 25 (n (%)) 0 0 0 0 0 0
↓ BMI < 30 >25 (n (%)) 4 (2,1) 2 (0,5) 2 (0,6) 4 (1,4) NP 6 (1,8)
PDT (n (%)) 10 (5,3) 9 (2,1) 9 (2,8) 10 (3,4) 2 (0,7) 17 (4,9)
BMI<25 pass to normoweight ; ↓ to BMI: Has reduced to the corresponding BMI; NP: not appropriate.
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th. In the V%FL in the case of women, men, in both 
the overweight and the obese, the loss was gradual, 
however in the case of comparison by age a weight 
reduction was noted up to the third or fourth month 
(Table II). In the V%PP and V%FL of the total sample 
only favourable results were obtained in the first mon-
th, the same trend according to sex, age and degree of 
BMI (Table III). 
Discussion
Strengths of the study 
The following points require mention: the inter-
vention of only one nutritionist, eliminating possi-
ble bias in interpretation; six years of data compila-
tion which permit observation of any improvement 
that the treatment requires; the number of patients of 
both sexes, the age range, the observation period per 
subject and the number of consultations evaluated; 
the patient’s access to the professional without time 
restrictions, the use of a personalised qualitative and 
quantitative diet based on locally grown foods, wi-
thout any need to measure exactly the weight of the 
food used, which makes monitoring of the treatment 
easier.
Abandonment and adherence to  
the treatment
This research has been characterised by a low per-
centage of abandonment, despite the breadth of the 
sample and the treatment time, highlighting a hi-
gher level of men, the over 45s and the obese. Other 
authors obtained between 48% and 68% abandon-
ment10,18. Using a diet adapted to the patient’s habits, 
with locally sourced foods and easy measurement of 
the amounts of foods used, pursues two objectives: 
the dietary treatment is better adapted to the patient, 
and also the fact that this type of method may be 
applied in different public institutions (health cen-
tres, hospitals etc). 
Parameters for interpretation of the loss 
Two new indicators were proposed in order to eva-
luate the weight loss: the quality (QL) and the varia-
bility (V%WL and V%FL) which will help to make 
comparisons in any clinical trial carried out with hu-
mans at different times during the treatment, irres-
pective of their sex, age and BMI. Therefore, it will 
permit recognition of exactly when and in what con-
ditions a treatment is most effective. The variability 
Fig. 1.—Evolution of 
the total sample during 
the six months of treat-
ment.
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of fat and weight loss provides a way of observing 
the relation between the monthly loss, and the total 
loss and the changes to health, that is, it will be pos-
sible to ascertain in which month the best or worst 
results are obtained with respect to the treatment as 
a whole. And the QL is recommended as a comple-
ment when determining the efficacy of a treatment, 
which should be based on the quantity and quality of 
the weight lost. In order to evaluate and distinguish 
between subjects of different sexes, ages and levels 
of excess weight, it is recommended that the term of 
variability be used, not only for taking into account 
the monthly loss but also the total weight loss, howe-
ver, in order to evaluate the loss of a single individual 
and the solution of possible pathologies caused by 
excess weight, it is more interesting to use the quality 
of loss, as the variation in body fat is related to the 
state of health1-3. 
Table II 
%WL, %FL, QL, V%WL, V%FL in patients who remain, according to sex, age groups and excess weight or obesity 
(average and standard deviation)
Treat-ment Change-ful Men
n=188
Woman
n=428
25-44 years
n=322
>45 years
n=294
Overweight
n=275
Obesity
n=341
1st month %WL 4,4(2,3) * 4,0(2,4) * 4,1(2,7) 4,0(2,0) 4,2(2,6) 4,0(2,1)
%FL 11,1(8,3) *** 7,6(6,0) *** 9,5(7,8) ** 7,8(6,0) ** 9,9(7,7) *** 7,7(6,2) ***
QL 3,1(5,4) *** 2,2(2,3) *** 2,9(4,6) * 2,1(2,0) * 2,5(2,9) *** 2,4(4,0) ***
V%WL 36,5(38,2) 25,6(57,5) 26,4(63,1) 31,5(38,4) 22,6(68,0) * 33,8(35,5) *
V%FL 43,9(47,1) * 35,8(60,2) * 37,0(52,0) 39,7(61,3) 35,6(56,9) * 40,4(56,5) *
2nd month %WL 3,1(2,3) 2,8(2,5) 3,1(2,4) 2,8(2,4) 2,9(2,4) 2,9(2,4)
%FL 9,4(8,3) *** 6,3(6,7) *** 7,4(7,3) 7,3(7,5) 8,2(8,2) 6,9(6,9)
QL 2,5(5,2) *** 1,7(8,2) *** 1,2(8,0) 2,4(6,9) 1,9(9,8) 2,8(5,5)
V%WL 70,8(25,6) 71,6(60,0 69,2(65,4) 73,1(33,9) 69,6(74,8) 72,3(30,2)
V%FL 65,5(29,8) 62,8(75,8) 55,6(80,7) 70,7(43,5) 51,0(89,9) * 70,9(41,2) *
3rd month %WL 2,1(1,9) 2,3(1,9) 2,7(1,9) * 1,9(1,9) * 1,7(1,7) 2,4(1,9)
%FL 7,0(10,1) ** 4,5(6,0) ** 7,0(6,0) ** 4,6(8,9) ** 4,8(6,6) 5,7(8,4)
QL 1,8(13,7) 2,9(5,4) 2,9(7,1) 2,4(11,3) 3,8(5,0) 2,2(10,4)
V%WL 82,5(17,8) 79,4(18,2) 76,2(16,8) 83,2(18,3 82,7(16,8) 80,1(18,4)
V%FL 82,0(27,8) 77,3(30,8) 73,6(27,9) 82,5(30,3) 81,6(29,5) * 78,6(29,8) *
4th month %WL 1,6(1,4) 1,4(2,2) 1,2(1,8) 1,7(1,8) 1,2(1,3) 1,5(1,8)
%FL 4,4(5,8) 3,4(6,0) 3,5(6,1) 4,1(5,9) 2,0(7,1) 4,0(5,8)
QL 1,4(14,5) 2,8(3,1) 2,6(5,1) 1,8(13,3) 4,8(5,3) 1,9(10,7)
V%WL 87,6(10,9) 98,0(39,5) 90,5(13,7) 94,0(35,0) 88,3(15,4) 93,1(29,9)
V%FL 85,9(20,5) 89,9(20,0) 91,8(17,3) 85,5(21,7) 89,7(34,3) 87,7(19,1)
5th month %WL 1,3(1,2) 1,5(2,1) 1,1(1,7) 1,5(1,7) 1,7(0,7) 1,4(1,7)
%FL 3,4(5,0) 3,9(5,1) 4,0(3,0) 3,5(5,7) 7,9(4,0) 3,2(4,9)
QL 1,8(10,1) 4,5(7,1) 6,3(10,1) 2,1(8,9) 5,6(4,7) 2,8(9,1)
V%WL 91,2(13,5) 92,9(13,8) 93,8(8,9) 91,2(15,0) 79,5(3,5) 93,3(13,3)
V%PG 84,9(23,3) 97,8(40,2) 89,0(9,1) 91,5(38,0) 52,5(1,2) * 95,0(30,6) *
6th month V%FL -0,5(1,9) ** 2,4(1,8) ** 0,1(2,2) 1,2(2,4) NP 0,9(2,3)
%FL 2,9(3,8) 4,4(6,4) 2,8(2,8) 3,9(5,8) NP 3,6(5,0)
QL 6,4(14,9) -0,4(6,6) 10,2(18,1) 0,1(7,8) NP 3,0(11,6)
V%WL 89,9(26,3) 82,9(7,1) 98,1(14,9) 81,6(19,8) NP 86,7(19,5)
V%FL 88,1(16,4) 116,6(79,1) 91,7(7,8) 105,5(66,0) NP 101,3(54,4)
NP: not appropriate; * p=0,05; ** p<0,05; *** p<0,01.
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The effectiveness of the loss between the variables
Men and women showed significant differences in 
%WL, %FL and QL in the first months, in V%WL and 
V%FL in the first month only. This indicates that when 
the monthly variation is observed, it can be seen how 
men obtain a greater loss in terms of quantity and qua-
lity than women, however, when the relation between 
monthly and total loss is taken into account, the diffe-
rences are reduced. If this issue is considered and the 
fact that women lose the same or more weight and fat 
in the final months of the treatment, it may indicate 
that despite the findings, women are more constant. A 
relation is found between the terms %WL, %FL and 
QL, however this does not occur with the relation be-
tween %WL, %FL, V%WL and V%FL. In those under 
or over 45 years, there are significant differences in 
%WL, %FL and QL, only in the first month, this indi-
cates that only in that month are differences in the loss 
based on age obtained. In terms of excess weight and 
obesity, differences in WL, %FL, V%WL and QL are 
only found in the first month, despite the fact that in 
the obese, significant variations were noted in V%FL, 
up to the end of treatment, this indicates that the die-
tary treatment is especially effective due to the varia-
bility of the fat loss. In all cases a random relation is 
shown between the variables of %WL, %FL, V%WL 
y V%FL. 
The waist and hip measurement is being introdu-
ced as an indicator of body fat, and already some stu-
dies have shown interest in differences in weight loss 
between the sexes and that in men it is more frequent 
for the weight loss to be associated with body fat than 
in women19. Based on these facts it is recommended 
that there should be further research on the effective-
ness of loss according to sex, age and BMI. Current 
clinical trials focus on the efficacy of the treatment 
applied, without taking into account the possible di-
fferences according to the characteristics of patients, 
such as gender, age, BMI etc 20-22. Therefore it is re-
commended that these variables should be treated as 
dependent, rather than independent as is currently the 
case. 
Effectiveness of the loss based on treatment time
In the development of the degree of weight loss as 
opposed to treatment time, the efficacy is notable up 
to the third month of treatment and the high amount 
of fat lost through variation of %FL and V%FL. In 
the case of QL, only a worsening of the results obtai-
ned on excessive weight were observed, this indica-
tes that the quality of weight loss in men, women, the 
obese, minors and those over 45 years, improves as 
the patient’s treatment progresses. Notwithstanding 
this fact, a gradual reduction of %WL, %FL, V%WL 
y V%FL was noted, which shows that individualised 
dietary treatment as a qualitative - quantitative me-
thod does not appear to affect the amount of weight 
loss from the sixth month onwards, however, it is 
possible to evaluate through the concept of quality 
of weight loss, that the minority of subjects who con-
tinue to lose weight when they reach the sixth mon-
th of treatment do so above all in terms of fat loss. 
This indicates that its multidisciplinary use should be 
recommended from the sixth month, particularly in 
morbid obesities which need more than six month’s 
treatment.
The relation between age, gender, BMI and effecti-
veness and the treatment time is not usually considered 
as a line of research. In most clinical trials time is pre-
sented as a descriptive factor, without determining the 
effectiveness as a dependent variable20,21. 
Consensus in the mode of expression of the loss. 
It is recommended that consensus be established 
in the expression of the effectiveness of the dietary 
treatment, in this study it is recommended that the 
following variables be used: percentage of weight 
and fat loss, variability and quality, particularly from 
this line of research it is reiterated that homogeneity 
should be established in expressing the results of a 
weight loss treatment4,23. This recommendation is ba-
sed on the need for any weight variation programme 
to show as clearly as possible in the results offered, 
whether it is evaluating subjects of a different gender, 
age, level of BMI and including in the case of spor-
ting subjects. 
Limitations of the study 
The following points should be mentioned: in this 
study only individualised use is evaluated, not groups 
or multidisciplinary use; nutritional education classes 
are recommended for groups in order to make commu-
nal learning more efficient, and the fact that the parti-
cipants were not obtained from public institutions, this 
last question is due to a problem existing in Spain, as 
in our country nutritionists and dieticians are not part 
of the national health system.
Table III 
Evolution of the V%WL and V%FL in  
the total sample during the six months
Treat-ment V%TWLS V%FLTS
1st month 28,9(52,6) 38,4(56,6) 
2nd month 71,4(50,9) 63,7(63,8)
3rd month 80,6(18,0) 79,2(29,6)
4th month 92,7(28,9) 87,8(20,2)
5th month 92,0(13,3) 90,7(31,8) 
6th month 86,7(19,5) 101,3(54,4)
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Conclusions 
Consensus and communication with the patient 
helps to maximise monitoring, effectiveness of the 
treatment and reduces the levels of abandonment. 
Two new terms are proposed: quality and variability 
of loss, as both help to determine the effectiveness of a 
treatment based on quantity and quality of weight loss, 
irrespective of age, sex, physical activity carried out, 
etc. Creation of a consensus is proposed in the expres-
sion of weight loss results. 
Significant differences in weight loss were noted 
between dependent variables: sex, age and degree of 
excess weight. Notwithstanding this fact, further work 
in this line of research is recommended. An individua-
lised qualitative- quantitative dietary treatment was 
proposed as a method for contributing to an adequate 
quality of fat loss. 
The variability and quality of the loss, show that the 
individualised dietary treatment is no longer effective 
after the sixth month. Unresolved obesities should be 
addressed in a multidisciplinary manner. 
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